E16.1

Billable

Other hypoglycemia

Other hypoglycemia

Status

Billable / Specific

Block

E15-E16

Parent Code

E16

ICD-11 Mapping

1 equivalent

Coding Notes

Inclusion Terms

Alternative clinical terms for this condition

  • Functional hyperinsulinism
  • Functional nonhyperinsulinemic hypoglycemia
  • Hyperinsulinism NOS
  • Hyperplasia of pancreatic islet beta cells NOS

Use Additional Code

Additional codes that should follow this code

Related Codes(7)
ICD-11 Equivalents(1)
Also Known As / Clinical Terms(327)

SNOMED CT

Clinical Terms

  • Pancreatic endocrine cell hyperplasia
  • Autosomal dominant hyperinsulinism due to SUR1 deficiency
  • Autosomal recessive hyperinsulinism due to sulfonylurea receptor 1 deficiency
  • Ectopic IGF-1 hypoglycemia
  • Hyperinsulinaemia due to malignant insulinoma
  • Autosomal dominant hyperinsulinism due to sulfonylurea receptor 1 deficiency
  • Hyperinsulinism due to uncoupling protein 2 deficiency
  • Diazoxide-sensitive diffuse hyperinsulinism
  • Hypoglycemia
  • Tumor-induced hypoglycemia
  • Hyperinsulinism NOS
  • Post hypoglycaemic hyperglycaemia due to diabetes mellitus
  • Postprandial hypoglycaemia
  • Tumour-induced hypoglycaemia
  • Ketotic hypoglycemia
  • Glutamate dehydrogenase 1 related hyperinsulinism and hyperammonaemia syndrome
  • Increased insulin
  • Hyperinsulinemic hypoglycaemia, diazoxide-resistant focal form
  • Pancreatic beta cell hyperplasia
  • Ketotic hypoglycaemia
  • Hyperinsulinemia
  • Fasting hypoglycaemia
  • Hyperinsulinism due to short chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
  • Hyperplasia of pancreatic islet beta cell (disorder)
  • Hyperammonaemia
  • Hyperinsulinaemia due to ectopic tumour source
  • Tumour-induced hyperinsulinaemia
  • Diazoxide-resistant hyperinsulinism
  • Non-diabetic hypoglycemia
  • insulin high
  • Pancreatic islet beta cell hyperplasia
  • Exercise-induced hyperinsulinemic hypoglycemia
  • Recurrent severe hypoglycemia
  • Ectopic insulin-like growth factor-1 hypoglycemia
  • Ectopic IGF hypoglycaemia
  • Post hypoglycemic hyperglycemia due to diabetes mellitus
  • Somogyi phenomenon
  • Hyperinsulinism due to hepatocyte nuclear factor 1-alpha deficiency
  • Hyperinsulinism due to UCP2 deficiency
  • Hyperinsulinism
  • increasing insulin
  • Idiopathic postprandial hypoglycemia
  • Fasting hypoglycemia
  • Diazoxide-resistant diffuse hyperinsulinism
  • Ectopic IGF hypoglycemia
  • Autosomal recessive hyperinsulinemic hypoglycaemia due to SUR1 deficiency
  • Non-diabetic hypoglycaemia
  • Hyperinsulinism due to hepatocyte nuclear factor 4-alpha deficiency
  • Ectopic IGF-1 hypoglycaemia
  • Hypoglycaemia of childhood
  • Alimentary hyperinsulinemia
  • Hyperammonemia
  • Iatrogenic hyperinsulinism
  • Hyperplasia of pancreatic islet beta cell
  • Hyperinsulinism due to glucokinase deficiency
  • Functional nonhyperinsulinemic hypoglycemia
  • FHH - familial hyperinsulinemic hypoglycemia
  • Mixed hypoglycaemia
  • high insulin
  • GLUD1 related hyperinsulinism and hyperammonaemia syndrome
  • Post-prandial hypoglycemia
  • Post-prandial hypoglycaemia
  • Exercise-induced hyperinsulinism
  • Glutamate dehydrogenase 1 related hyperinsulinism and hyperammonemia syndrome
  • Hyperinsulinism due to INSR (insulin receptor) deficiency
  • Hyperinsulinemia due to malignant insulinoma
  • Hypoglycemia due to neoplasm
  • Hyperinsulinism (disorder)
  • FHH - familial hyperinsulinemic hypoglycaemia
  • Hypoglycemia of childhood
  • Ectopic hyperinsulinemia
  • Post gastrointestinal tract surgery hypoglycaemia
  • Ectopic insulin-like growth factor-2 hypoglycemia
  • Hyperinsulinaemia
  • Hyperinsulinism and hyperammonaemia syndrome
  • Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency
  • Hyperinsulinemic hypoglycaemia, diazoxide-resistant diffuse form
  • Diazoxide-resistant focal hyperinsulinism
  • GLUD1 related hyperinsulinism and hyperammonemia syndrome
  • Alimentary hyperinsulinaemia
  • Autosomal recessive hyperinsulinemic hypoglycaemia due to Kir6.2 deficiency
  • Hyperinsulinemic hypoglycemia, diazoxide-sensitive diffuse form
  • Hypoglycemia of infancy
  • Elevated insulin levels
  • Hyperinsulinism and hyperammonemia syndrome
  • Insulin increased
  • Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
  • Idiopathic postprandial hypoglycaemia
  • Hyperinsulinism syndrome
  • Diazoxide-resistant hyperinsulinemic hypoglycaemia
  • Hypoglycaemia of infancy
  • Hyperinsulinemic hypoglycaemia due to Kir6.2 deficiency, diazoxide-resistant focal form
  • Tumor-induced hyperinsulinemia
  • Hypoglycaemia due to neoplasm
  • Neuroglycopenia
  • Hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form
  • Diazoxide-resistant focal hyperinsulinism due to sulfonylurea receptor 1 deficiency
  • Recurrent severe hypoglycaemia
  • Hypoglycemic reaction
  • Ectopic insulin-like growth factor hypoglycemia
  • Hyperinsulinism due to insulin receptor deficiency
  • Autosomal recessive hyperinsulinism due to SUR1 deficiency
  • Exercise-induced hyperinsulinaemic hypoglycaemia
  • Elevated insulin level
  • hyperinsulism
  • Ectopic hyperinsulinism
  • Hyperinsulinemic hypoglycaemia, diazoxide-sensitive diffuse form
  • Hyperglycemia due to diabetes mellitus
  • Hyperinsulinism due to HNF1A deficiency
  • Hyperinsulinism due to UCP2 (uncoupling protein 2) deficiency
  • Metabolic complication of procedures
  • Autosomal recessive hyperinsulinemic hypoglycemia due to SUR1 deficiency
  • Hyperinsulinism due to HNF4A deficiency
  • Postprandial hypoglycemia
  • Mixed hypoglycemia
  • Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency
  • Diazoxide-resistant hyperinsulinemic hypoglycemia
  • Ectopic insulin-like growth factor-1 hypoglycaemia
  • Autosomal recessive hyperinsulinism due to Kir6.2 deficiency
  • Hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, diazoxide-resistant focal form
  • Hyperinsulinemia due to ectopic tumor source
  • Impaired glucose tolerance with hyperinsulism
  • Hyperinsulinemic hypoglycemia, diazoxide-resistant diffuse form
  • Autoimmune hypoglycemia
  • Ectopic IGF-2 hypoglycaemia
  • Hyperinsulinemic hypoglycemia, diazoxide-resistant focal form
  • Functional hyperinsulinemia
  • Hyperinsulinemic hypoglycaemia due to SUR1 deficiency, diazoxide-resistant focal form
  • Hypoglycaemia
  • Ectopic insulin-like growth factor hypoglycaemia
  • Autoimmune hypoglycaemia
  • Ectopic insulin-like growth factor-2 hypoglycaemia
  • Functional hyperinsulinaemia
  • Autosomal dominant hyperinsulinism due to Kir6.2 deficiency
  • Ectopic IGF-2 hypoglycemia
  • Functional hyperinsulinism
  • Hypoglycaemic reaction
  • Familial hyperinsulinemic hypoglycemia
  • Autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency
  • Nesidioblastosis
  • Islet cell hyperplasia
  • Alimentary hypoglycemia
  • Post gastrointestinal tract surgery hypoglycemia
  • Reactive hypoglycemia
  • Iatrogenic hyperinsulinaemia
  • Non-diabetic disorder of endocrine pancreas
  • Hyperinsulinism due to focal adenomatous hyperplasia
  • Familial hyperinsulinemic hypoglycaemia
  • Iatrogenic hyperinsulinemia
  • Hyperinsulinism due to deficiency of glucokinase
  • Functional hyperinsulinism (disorder)
  • Reactive hypoglycaemia
  • Hyperplasia of pancreatic islet beta cells NOS
  • Hyperglycaemia due to diabetes mellitus
  • Ectopic hyperinsulinaemia
  • Alimentary hypoglycaemia
Frequently Asked Questions
What is the ICD-10 code for other hypoglycemia?

The ICD-10-CM code for other hypoglycemia is E16.1. The full clinical description is "Other hypoglycemia". E16.1 is a billable/specific code that can be used on insurance claims and medical billing.

What does ICD-10 code E16.1 mean?

ICD-10-CM code E16.1 represents “Other hypoglycemia”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.

Is E16.1 a billable code?

Yes, E16.1 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

What chapter is E16.1 in?

E16.1 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).

What codes cannot be used with E16.1?

E16.1 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649); hypoglycemia in infant of diabetic mother (P70.1); and 1 more.

Are additional codes required with E16.1?

Yes, when using E16.1, also report: hypoglycemia level, if applicable (E16.A-).

What SNOMED CT codes does E16.1 map to?

E16.1 maps to 52 SNOMED CT concepts: 237647008, 237639008, 71858003, 717045004, 717046003, and 47 more. SNOMED CT is a clinical terminology used in electronic health records.

What are the UMLS CUIs for E16.1?

E16.1 is linked to 5 UMLS Concept Unique Identifiers: C0020459, C0271705, C2874178, C0271706, C0348452. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

How does E16.1 relate to ICF functioning codes?

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like other hypoglycemia affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

What is the ICD-11 equivalent of E16.1?

E16.1 maps to the ICD-11 code: 5A4Z (Disorders of glucose regulation or pancreatic internal secretion, unspecified).

Automate ICD-10 Coding With AI

Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.

Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.